Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review

Despite a good initial response to chemotherapy, the majority of patients with epithelial ovarian cancer will eventually recur and die of their disease. The introduction of targeted therapies to traditional chemotherapy regimens has done little to improve overall survival in women with ovarian cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Haller J., Straughn, J. Michael, Buchsbaum, Donald J., Arend, Rebecca C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369329/
https://www.ncbi.nlm.nih.gov/pubmed/28378010
http://dx.doi.org/10.1016/j.gore.2017.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369329/
https://www.ncbi.nlm.nih.gov/pubmed/28378010
http://dx.doi.org/10.1016/j.gore.2017.03.007

Ejemplares similares